Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Hemorrhoid Disease: A Review on Treatment, Clinical Research and Patent Data

Author(s): Vishakha Devi, Geeta Deswal, Rameshwar Dass, Bhawna Chopra, Priyanka Kriplani, Ajmer Singh Grewal and Ashwani K. Dhingra*

Volume 23, Issue 6, 2023

Published on: 22 May, 2023

Article ID: e270423216271 Pages: 21

DOI: 10.2174/1871526523666230427115436

Price: $65

Abstract

Background: Hemorrhoid disease (HD) is an anal-rectal ailment that is commonly painful or may be painless and causes rectal bleeding with or without prolapsing anal tissue. It is generally associated with bleeding, prolapse, pruritus, and discomfort, which results in a diminished quality of life and well-being.

Objective: To highlight the recent developments in terms of safety, clinical efficacy, and marketed formulation for the effective management of hemorrhoids.

Method: Reported literature available on Scopus, PubMed, Science Direct, Clinicaltrails.gov, and from many reputed foundations has been studied to summarize the recent development and clinical studies for the management of hemorrhoids.

Results and Conclusion: The high incidence of hemorrhoids obliges the development of new molecules; therefore, safe and efficient drugs to confer protection against hemorrhoids are urgently needed. This review article mainly focuses on the newer molecules to overcome hemorrhoids and also emphasizes various studies carried out in the past.

Graphical Abstract

[1]
Xu L, Chen H, Gu Y. Stapled hemorrhoidectomy versus transanal hemorrhoidal dearterialization in the treatment of hemorrhoids: An updated meta-analysis. Surg Laparosc Endosc Percutan Tech 2019; 29(2): 75-81.
[http://dx.doi.org/10.1097/SLE.0000000000000612] [PMID: 30540639]
[2]
Guindic LC. Treatment of uncomplicated hemorrhoids with a Hemor-Rite® cryotherapy device: a randomized, prospective, comparative study. J Pain Res 2014; 7: 57-63.
[PMID: 24474845]
[3]
Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist’s view. World J Gastroenterol 2015; 21(31): 9245-52.
[http://dx.doi.org/10.3748/wjg.v21.i31.9245] [PMID: 26309351]
[4]
Sardinha TC, Corman ML. Hemorrhoids. Surg Clin North Am 2002; 82(6): 1153-1167, vi.
[http://dx.doi.org/10.1016/S0039-6109(02)00082-8] [PMID: 12516845]
[5]
Sandler RS, Peery AF. Rethinking what we know about hemorrhoids. Clin Gastroenterol Hepatol 2019; 17(1): 8-15.
[http://dx.doi.org/10.1016/j.cgh.2018.03.020] [PMID: 29601902]
[6]
Mott T, Latimer K, Edwards C. Hemorrhoids: Diagnosis and treatment options. Am Fam Physician 2018; 97(3): 172-9.
[PMID: 29431977]
[7]
Guttenplan M. The evaluation and office management of hemorrhoids for the gastroenterologist. Curr Gastroenterol Rep 2017; 19(7): 30.
[http://dx.doi.org/10.1007/s11894-017-0574-9] [PMID: 28567655]
[8]
Reese GE, von Roon AC, Tekkis PP. Haemorrhoids. BMJ Clin Evid 2009; 2009: 0415.
[9]
De Schepper H, Coremans G, Denis MA, et al. Belgian consensus guideline on the management of hemorrhoidal disease. Acta Gastroenterol Belg 2021; 84(1): 101-20.
[http://dx.doi.org/10.51821/84.1.497] [PMID: 33639701]
[10]
Migaly J, Sun Z. Review of hemorrhoid disease: Presentation and management. Clin Colon Rectal Surg 2016; 29(1): 022-9.
[http://dx.doi.org/10.1055/s-0035-1568144] [PMID: 26929748]
[11]
Zagriadskiĭ EA, Bogomazov AM, Golovko EB. Conservative treatment of hemorrhoids: Results of an observational multicenter study. Adv Ther 2018; 35(11): 1979-92.
[http://dx.doi.org/10.1007/s12325-018-0794-x] [PMID: 30276625]
[12]
Ray-Offor E, Amadi S. Hemorrhoidal disease: Predilection sites, pattern of presentation, and treatment. Ann Afr Med 2019; 18(1): 12-6.
[http://dx.doi.org/10.4103/aam.aam_4_18] [PMID: 30729927]
[13]
Yano T, Asano M, Tanaka S, Oda N, Matsuda Y. A prospective study comparing the new sclerotherapy and hemorrhoidectomy in terms of therapeutic outcomes at 4 years after the treatment. Surg Today 2014; 44(3): 449-53.
[http://dx.doi.org/10.1007/s00595-013-0564-y] [PMID: 23543083]
[14]
Nasseri YY, Krott E, Van Groningen KM, et al. Abnormalities in collagen composition may contribute to the pathogenesis of hemorrhoids: morphometric analysis. Tech Coloproctol 2015; 19(2): 83-7.
[http://dx.doi.org/10.1007/s10151-014-1238-5] [PMID: 25381456]
[15]
Serra R, Gallelli L, Grande R, et al. Hemorrhoids and matrix metalloproteinases: A multicenter study on the predictive role of biomarkers. Surgery 2016; 159(2): 487-94.
[http://dx.doi.org/10.1016/j.surg.2015.07.003] [PMID: 26263832]
[16]
Jacobs DO. Hemorrhoids. Curr Opin Gastroenterol 2018; 34(1): 46-9.
[http://dx.doi.org/10.1097/MOG.0000000000000408] [PMID: 29076869]
[17]
Ma W, Guo J, Yang F, Dietrich CF, Sun S. Progress in endoscopic treatment of hemorrhoids. J Transl Int Med 2020; 8(4): 237-44.
[http://dx.doi.org/10.2478/jtim-2020-0036] [PMID: 33511050]
[18]
Dennison AR, Wherry DC, Morris DL. Hemorrhoids: Nonoperative management. Surg Clin North Am 1988; 68(6): 1401-9.
[http://dx.doi.org/10.1016/S0039-6109(16)44695-5] [PMID: 3057666]
[19]
Iyer VS, Shrier I, Gordon PH. Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum 2004; 47(9): 1364-70.
[http://dx.doi.org/10.1007/s10350-004-0591-2] [PMID: 15484351]
[20]
Siddiqui UD, Barth BA, Banerjee S, et al. Devices for the endoscopic treatment of hemorrhoids. Gastrointest Endosc 2014; 79(1): 8-14.
[http://dx.doi.org/10.1016/j.gie.2013.07.021] [PMID: 24239254]
[21]
Albuquerque A. Rubber band ligation of hemorrhoids: A guide for complications. World J Gastrointest Surg 2016; 8(9): 614-20.
[http://dx.doi.org/10.4240/wjgs.v8.i9.614] [PMID: 27721924]
[22]
Jakubauskas M, Poskus T. Evaluation and management of hemorrhoids. Dis Colon Rectum 2020; 63(4): 420-4.
[http://dx.doi.org/10.1097/DCR.0000000000001642] [PMID: 32132463]
[23]
Poon GP, Chu KW, Lau WY, et al. Conventional vs. triple rubber band ligation for hemorrhoids. Dis Colon Rectum 1986; 29(12): 836-8.
[http://dx.doi.org/10.1007/BF02555358] [PMID: 3539557]
[24]
Halverson A. Hemorrhoids. Clin Colon Rectal Surg 2007; 20(2): 77-85.
[http://dx.doi.org/10.1055/s-2007-977485] [PMID: 20011381]
[25]
Shanmugam V, Hakeem A, Campbell KL, et al. Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids. Cochrane Libr 2005; 2011(3): CD005034.
[http://dx.doi.org/10.1002/14651858.CD005034.pub2] [PMID: 16034963]
[26]
Gupta PJ. Infrared coagulation versus rubber band ligation in early stage hemorrhoids. Braz J Med Biol Res 2003; 36(10): 1433-9.
[http://dx.doi.org/10.1590/S0100-879X2003001000022] [PMID: 14502378]
[27]
Komporozos V, Ziozia V, Komporozou A, Stravodimos G, Kolinioti A, Papazoglou A. Rubber band ligation of symptomatic hemorrhoids: an old solution to an everyday problem. Int J Colorectal Dis 2021; 36(8): 1723-9.
[http://dx.doi.org/10.1007/s00384-021-03900-2] [PMID: 33751210]
[28]
Jin L, Yang H, Qin K, et al. Efficacy of modified rubber band ligation in the treatment of grade III internal hemorrhoids. Ann Palliat Med 2021; 10(2): 1191-7.
[http://dx.doi.org/10.21037/apm-19-657] [PMID: 33081476]
[29]
Rutala WA, Gergen MF, Weber DJ. Disinfection of an infrared coagulation device used to treat hemorrhoids. Am J Infect Control 2012; 40(1): 78-9.
[http://dx.doi.org/10.1016/j.ajic.2011.04.330] [PMID: 21835503]
[30]
Neiger A. Infrared-photo-coagulation for hemorrhoids treatment. Int Surg 1989; 74(3): 142-3.
[PMID: 2606612]
[31]
Ahmad A, Kant R, Gupta A. Comparative analysis of doppler guided hemorrhoidal artery ligation (DG-HAL) & Infrared Coagulation (IRC) in management of hemorrhoids. Indian J Surg 2013; 75(4): 274-7.
[http://dx.doi.org/10.1007/s12262-012-0444-5] [PMID: 24426452]
[32]
Pfenninger JL, Surrell J. Nonsurgical treatment options for internal hemorrhoids. Am Fam Physician 1995; 52(3): 821-834, 839-841.
[PMID: 7653423]
[33]
Leicester RJ, John NR, Mann CV. Infrared coagulation: A new treatment for hemorrhoids. Dis Colon Rectum 1981; 24(8): 602-5.
[http://dx.doi.org/10.1007/BF02605755] [PMID: 7318625]
[34]
McLemore EC, Rai R, Siddiqui J, Patrick Basu P, Tabbaa M, Epstein MS. Novel endoscopic delivery modality of infrared coagulation therapy for internal hemorrhoids. Surg Endosc 2012; 26(11): 3082-7.
[http://dx.doi.org/10.1007/s00464-012-2325-1] [PMID: 22648099]
[35]
Acharya YT, Ed. Varanasi: Chaukhambha Orientalia. Samhita of Sushruta, Chikitsa Sthana 2009; 6.
[36]
Ricci MP, Matos D, Saad SS. Rubber band ligation and infrared photocoagulation for the outpatient treatment of hemorrhoidal disease. Acta Cir Bras 2008; 23(1): 102-6.
[http://dx.doi.org/10.1590/S0102-86502008000100016] [PMID: 18278400]
[37]
MacLeod JH. In defense of cryotherapy for hemorrhoids. Dis Colon Rectum 1982; 25(4): 332-5.
[http://dx.doi.org/10.1007/BF02553608] [PMID: 6979469]
[38]
Guy RJ, Seow-Choen F. Septic complications after treatment of haemorrhoids. Br J Surg 2003; 90(2): 147-56.
[http://dx.doi.org/10.1002/bjs.4008] [PMID: 12555289]
[39]
Tol RR, Kleijnen J, Watson AJM, et al. European Society of ColoProctology: Guideline for haemorrhoidal disease. Colorectal Dis 2020; 22(6): 650-62.
[http://dx.doi.org/10.1111/codi.14975] [PMID: 32067353]
[40]
Piskun G, Tucker R. New bipolar tissue ligator combines constant tissue compression and temperature guidance: Histologic study and implications for treatment of hemorrhoids. Med Devices 2012; 5: 89-96.
[http://dx.doi.org/10.2147/MDER.S34390] [PMID: 23152714]
[41]
Kantsevoy SV, Bitner M. Nonsurgical treatment of actively bleeding internal hemorrhoids with a novel endoscopic device (with video). Gastrointest Endosc 2013; 78(4): 649-53.
[http://dx.doi.org/10.1016/j.gie.2013.05.014] [PMID: 23891414]
[42]
Gupta PJ. Radiofrequency ablation and plication: A non-resectional therapy for advanced hemorrhoids. J Surg Res 2005; 126(1): 66-72.
[http://dx.doi.org/10.1016/j.jss.2005.01.020] [PMID: 15916977]
[43]
Gupta PJ. Radiofrequency coagulation versus rubber band ligation in early hemorrhoids: pain versus gain. Medicina 2004; 40(3): 232-7.
[PMID: 15064544]
[44]
Talaie R, Torkian P, Moghadam AD, et al. Hemorrhoid embolization: A review of current evidences. Diagn Interv Imaging 2022; 103(1): 3-11.
[http://dx.doi.org/10.1016/j.diii.2021.07.001] [PMID: 34456172]
[45]
Nguyenhuy M, Xu Y, Kok HK, et al. Clinical outcomes following rectal artery embolisation for the treatment of internal haemorrhoids: A systematic review and meta-analysis. Cardiovasc Intervent Radiol 2022; 45(9): 1351-61.
[http://dx.doi.org/10.1007/s00270-022-03154-7] [PMID: 35551442]
[46]
Panneau J, Mege D, Di Bisceglie M, et al. Rectal artery embolization for hemorrhoidal disease: Anatomy, evaluation, and treatment techniques. Radiographics 2022; 42(7): E226.
[http://dx.doi.org/10.1148/rg.229013] [PMID: 36318493]
[47]
Ganz RA. The evaluation and treatment of hemorrhoids: A guide for the gastroenterologist. Clin Gastroenterol Hepatol 2013; 11(6): 593-603.
[http://dx.doi.org/10.1016/j.cgh.2012.12.020] [PMID: 23333220]
[48]
Jacobs D. Hemorrhoids N Engl J Med 2014; 371(10): 944-51.
[http://dx.doi.org/10.1056/NEJMcp1204188] [PMID: 25184866]
[49]
Milone M, Maietta P, Leongito M, Pesce G, Salvatore G, Milone F. Ferguson hemorrhoidectomy: Is still the gold standard treatment? Updates Surg 2012; 64(3): 191-4.
[http://dx.doi.org/10.1007/s13304-012-0155-2] [PMID: 22488271]
[50]
Acheson AG, Scholefield JH. Management of haemorrhoids. BMJ 2008; 336(7640): 380-3.
[http://dx.doi.org/10.1136/bmj.39465.674745.80] [PMID: 18276714]
[51]
Altomare DF, Giannini I. Pharmacological treatment of hemorrhoids: A narrative review. Expert Opin Pharmacother 2013; 14(17): 2343-9.
[http://dx.doi.org/10.1517/14656566.2013.836181] [PMID: 24024752]
[52]
Johanson J. Nonsurgical treatment of hemorrhoids. J Gastrointest Surg 2002; 6(3): 290-4.
[http://dx.doi.org/10.1016/S1091-255X(01)00081-6] [PMID: 12022975]
[53]
Dhingra AK, Chopra B. Inflammation as a therapeutic target for various deadly disorders: A review. Curr Drug Targets 2020; 21(6): 582-8.
[http://dx.doi.org/10.2174/1389450120666191204154115] [PMID: 31801453]
[54]
Menteş BB, Görgül A, Tatlicioğlu E, Ayoğlu F, Ünal S. Efficacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease. Dis Colon Rectum 2001; 44(10): 1489-95.
[http://dx.doi.org/10.1007/BF02234604] [PMID: 11598479]
[55]
Tjandra JJ, Tan JJY, Lim JF, Murray-Green C, Kennedy ML, Lubowski DZ. Rectogesic® (glyceryl trinitrate 0.2%) ointment relieves symptoms of haemorrhoids associated with high resting anal canal pressures. Colorectal Dis 2007; 9(5): 457-63.
[http://dx.doi.org/10.1111/j.1463-1318.2006.01134.x] [PMID: 17504344]
[56]
Perrotti P, Antropoli C, Molino D, De Stefano G, Antropoli M. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Colon Rectum 2001; 44(3): 405-9.
[http://dx.doi.org/10.1007/BF02234741] [PMID: 11289288]
[57]
Labrid C. Pharmacologic properties of Daflon 500 mg. Angiology 1994; 45(6 Pt 2): 524-30.
[58]
Labrid C. A lymphatic function of Daflon 500 mg. Int Angiol 1995; 14(S3): 36-8.
[59]
Struckmann JR, Nicolaides AN. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology 1994; 45(6): 419-28.
[http://dx.doi.org/10.1177/0003319794045006021] [PMID: 8203767]
[60]
Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 2006; 93(8): 909-20.
[http://dx.doi.org/10.1002/bjs.5378] [PMID: 16736537]
[61]
La Torre F, Nicolai AP. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: Results of a randomized, controlled, clinical trial. Dis Colon Rectum 2004; 47(5): 704-10.
[http://dx.doi.org/10.1007/s10350-003-0119-1] [PMID: 15037936]
[62]
Lohsiriwat V. Approach to hemorrhoids. Curr Gastroenterol Rep 2013; 15(7): 332.
[http://dx.doi.org/10.1007/s11894-013-0332-6] [PMID: 23715885]
[63]
Alonso-Coello P, Mills E, Heels-Ansdell D, et al. Fiber for the treatment of hemorrhoids complications: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101(1): 181-8.
[http://dx.doi.org/10.1111/j.1572-0241.2005.00359.x] [PMID: 16405552]
[64]
MacKay D. Hemorrhoids and varicose veins: a review of treatment options. Altern Med Rev 2001; 6(2): 126-40.
[PMID: 11302778]
[65]
Madoff RD, Fleshman JW. American gastroenterological association technical review on the diagnosis and treatment of hemorrhoids1 1This literature review and the recommendations therein were prepared for the American Gastroenterological Association Clinical Practice Committee. The paper was approved by the Committee on January 8, 2004, and by the AGA Governing Board on February 13, 2004. Gastroenterology 2004; 126(5): 1463-73.
[http://dx.doi.org/10.1053/j.gastro.2004.03.008] [PMID: 15131807]
[66]
Yuan Q, Zhang X, Liu Z, et al. Ethanol extract of Adiantum capillus-veneris L. suppresses the production of inflammatory mediators by inhibiting NF-κB activation. J Ethnopharmacol 2013; 147(3): 603-11.
[http://dx.doi.org/10.1016/j.jep.2013.03.046] [PMID: 23542147]
[67]
Takahashi M, Shibamoto T. Chemical compositions and antioxidant/anti-inflammatory activities of steam distillate from freeze-dried onion (Allium cepa L.) sprout. J Agric Food Chem 2008; 56(22): 10462-7.
[http://dx.doi.org/10.1021/jf801220b] [PMID: 18942842]
[68]
Márquez L, Pérez-Nievas BG, Gárate I, et al. Anti-inflammatory effects of Mangifera indica L. extract in a model of colitis. World J Gastroenterol 2010; 16(39): 4922-31.
[http://dx.doi.org/10.3748/wjg.v16.i39.4922] [PMID: 20954278]
[69]
Ramprasath VR, Shanthi P, Sachdanandam P. Anti-inflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions. Biol Pharm Bull 2004; 27(12): 2028-31.
[http://dx.doi.org/10.1248/bpb.27.2028] [PMID: 15577226]
[70]
Lewis DA, Tharib SM, Veitch G, Bryan A. The anti-inflammatory activity of celery Apium graveolens L. (Fam. Umbelliferae). Pharm Biol 1985; 23(1): 27-32.
[71]
Mohamed DA, Al-Okbi SY. In vivo evaluation of antioxidant and anti-inflammatory activity of different extracts of date fruits in adjuvant arthritis. Pol J Food Nutr Sci 2004; 13: 397-402.
[72]
Rocha NFM, Rios ERV, Carvalho AMR, et al. Anti-nociceptive and anti-inflammatory activities of (−)-α-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol 2011; 384(6): 525-33.
[http://dx.doi.org/10.1007/s00210-011-0679-x] [PMID: 21870032]
[73]
Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996; 18(10): 553-61.
[http://dx.doi.org/10.1016/S0192-0561(96)00047-1] [PMID: 9080249]
[74]
Ammon HPT, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993; 38(2-3): 105-12.
[http://dx.doi.org/10.1016/0378-8741(93)90005-P] [PMID: 8510458]
[75]
Al-Yahya MA, Mossa JS, Ageel AM, Rafatullah S. Pharmacological and safety evaluation studies on Lepidium sativum L., Seeds. Phytomedicine 1994; 1(2): 155-9.
[http://dx.doi.org/10.1016/S0944-7113(11)80035-8] [PMID: 23195890]
[76]
Das SK, Ramakrishnan S, Mishra K, et al. A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: A preliminary report. Arthritis Rheum 2002; 47(3): 280-4.
[http://dx.doi.org/10.1002/art.10455] [PMID: 12115158]
[77]
Nair V, Singh S, Gupta YK. Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models. J Pharm Pharmacol 2010; 62(12): 1801-6.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01193.x] [PMID: 21054408]
[78]
Park CS, Lim H, Han KJ, et al. Inhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages. J Pharmacol Exp Ther 2004; 309(2): 705-10.
[http://dx.doi.org/10.1124/jpet.103.063693] [PMID: 14752064]
[79]
Ghasemi M, Golmakani E, Ahmadzadeh ST, Kamali H, Akaberi A, Bibak B. Study of methanol extract of Cyprus longus on visceral pain by writhing test in mice. J North Khorasan Uni Med Sci 2014; 6(1): 133-8.
[http://dx.doi.org/10.29252/jnkums.6.1.133]
[80]
Awaad AS, El-meligy RM, Qenawy SA, Atta AH, Soliman GA. Anti-inflammatory, antinociceptive and antipyretic effects of some desert plants. J Saudi Chem Soc 2011; 15(4): 367-73.
[http://dx.doi.org/10.1016/j.jscs.2011.02.004]
[81]
Marashdah MS, Farraj AI. Pharmacological activity of 2% aqueous acetic acid extract of Alhagi maurorum roots. J Saudi Chem Soc 2010; 14(3): 247-50.
[http://dx.doi.org/10.1016/j.jscs.2010.02.015]
[82]
Raso GM, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 2010; 54(10): 1379-83.
[http://dx.doi.org/10.1211/002235702760345464] [PMID: 12396300]
[83]
Sosa S, Pace R, Bornanciny A, et al. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol 2010; 59(5): 703-9.
[http://dx.doi.org/10.1211/jpp.59.5.0011] [PMID: 17524236]
[84]
Rahman A, Nasim S, Baig I, et al. Anti-inflammatory isoflavonoids from the rhizomes of Iris germanica. J Ethnopharmacol 2003; 86(2-3): 177-80.
[http://dx.doi.org/10.1016/S0378-8741(03)00055-2] [PMID: 12738083]
[85]
Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 2008; 99(4): 715-22.
[http://dx.doi.org/10.1017/S0007114507837421] [PMID: 17916277]
[86]
Choudhary MI, Azizuddin , Jalil S, et al. Antiinflammatory and lipoxygenase inhibitory compounds from vitex agnus-castus. Phytother Res 2009; 23(9): 1336-9.
[http://dx.doi.org/10.1002/ptr.2639] [PMID: 19173281]
[87]
de Fátima Navarro D, de Souza MM, Neto RA, et al. Phytochemical analysis and analgesic properties of Curcuma zedoaria grown in Brazil. Phytomedicine 2002; 9(5): 427-32.
[http://dx.doi.org/10.1078/09447110260571670] [PMID: 12222663]
[88]
Hosseinzadeh H, Khoshdel M, Ghorbani M. Antinociceptive, anti-inflammatory effects and acute toxicity of aqueous and ethanolic extracts of Myrtus communis L. Aerial parts in mice. J Acupunct Meridian Stud 2011; 4(4): 242-7.
[http://dx.doi.org/10.1016/j.jams.2011.09.015] [PMID: 22196507]
[89]
Farouk L, Laroubi A, Aboufatima R, Benharref A, Chait A. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: Possible mechanisms involved. J Ethnopharmacol 2008; 115(3): 449-54.
[http://dx.doi.org/10.1016/j.jep.2007.10.014] [PMID: 18054186]
[90]
Hashempur MH, Khademi F, Rahmanifard M, Zarshenas MM. An evidence-based study on medicinal plants for hemorrhoids in medieval persia. J Evid Based Complementary Altern Med 2017; 22(4): 969-81.
[http://dx.doi.org/10.1177/2156587216688597] [PMID: 29228790]
[91]
Lee YC, Kim SH, Roh SS, Choi HY, Seo YB. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice. J Ethnopharmacol 2007; 112(1): 40-8.
[http://dx.doi.org/10.1016/j.jep.2007.01.033] [PMID: 17353105]
[92]
Atil VV, Patil VR. Evaluation of anti-inflammatory activity of Ficus carica Linn. leaves. Indian J Nat Prod Resour 2011; 2: 151-5.
[93]
Monteiro É, Chibli L, Yamamoto C, et al. Antinociceptive and anti-inflammatory activities of the sesame oil and sesamin. Nutrients 2014; 6(5): 1931-44.
[http://dx.doi.org/10.3390/nu6051931] [PMID: 24824289]
[94]
Dang GK, Parekar RR, Kamat SK, Scindia AM, Rege NN. Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation. Phytother Res 2011; 25(6): 904-8.
[http://dx.doi.org/10.1002/ptr.3345] [PMID: 21132843]
[95]
Ozbek H, Erten R, Oner AC, Cengiz N, Yilmaz O, Turel I. Hepatoprotective and anti-inflammatory activities of Plantago major L. Indian J Pharmacol 2009; 41(3): 120-4.
[http://dx.doi.org/10.4103/0253-7613.55211] [PMID: 20442819]
[96]
Rao J, Jayasree T, Mallikarjuna Rao B, et al. Evaluation of the anti-nociceptive and anti-inflammatory activities of the pet:ether extract of Portulaca oleracea (Linn.). J Clin Diagn Res 2012; 6: 226-30.
[97]
Sood S, Bansal S, Muthuraman A, Gill NS, Bali M. Therapeutic potential of Citrus medica L. peel extract in carrageenan induced inflammatory pain in rat. Res J Med Plant 2009; 3(4): 123-33.
[http://dx.doi.org/10.3923/rjmp.2009.123.133]
[98]
Khan I, Nisar M, Ebad F, et al. Anti-inflammatory activities of Sieboldogenin from Smilax china Linn.: Experimental and computational studies. J Ethnopharmacol 2009; 121(1): 175-7.
[http://dx.doi.org/10.1016/j.jep.2008.10.009] [PMID: 19007873]
[99]
Mutalik S, Paridhavi K, Rao CM, Udupa N. Antipyretic and analgesic effect of leaves of Solanum melongena Linn. in rodents. Indian J Pharmacol 2003; 35: 312-5.
[100]
Pilipovic S, Mulabegovic N, Kovac-Besovic E, et al. Topical anti-inflammatory activity of ointments with 1% of crude water extracts of rhizoma and herb Potentilla reptans L. in croton oil model of mouse ear inflammation. Planta Med 2010; 76(12): 205.
[http://dx.doi.org/10.1055/s-0030-1264503]
[101]
Ibrahim AY, El-Gengaihi SE, Motawea HM, Sleem AA. Anti-inflammatory activity of Salvadora persica L. against carrageenan induced paw oedema in rat relevant to inflammatory cytokines. Not Sci Biol 2011; 3(4): 22-8.
[http://dx.doi.org/10.15835/nsb346378]
[102]
Vázquez B, Avila G, Segura D, Escalante B. Antiinflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 1996; 55(1): 69-75.
[http://dx.doi.org/10.1016/S0378-8741(96)01476-6] [PMID: 9121170]
[103]
Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of Aloe vera gel in human Colorectal mucosa in vitro. Aliment Pharmacol Ther 2004; 19(5): 521-7.
[http://dx.doi.org/10.1111/j.1365-2036.2004.01874.x] [PMID: 14987320]
[104]
Makabe H, Maru N, Kuwabara A, Kamo T, Hirota M. Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res 2006; 20(7): 680-5.
[http://dx.doi.org/10.1080/14786410500462900] [PMID: 16901812]
[105]
Julie D. The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids. NCT04031131. Available from: https://clinical-trials.gov/ct2/show/NCT04031131?recrs=e&cond=hemorrhoids
[106]
To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids. NCT01041911. Available from: https://clinicaltrials.gov/ct2/show/NCT01041911?recrs=e&cond=hemorrhoids
[107]
Prospective Randomized Trial About THD Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids (THD-LIGA). NCT02654249. Available from: https://clinicaltrials.gov/ct2/show/NCT02654249?recrs=e&cond=hemorrhoid
[108]
A Comparative Efficacy and Safety Study of Compound Carraghenates Cream with Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids. NCT01881282. Available from: https://clinicaltrials.gov/ct2/show/NCT01881282?recrs=e&cond=hemorrhoids
[109]
HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment (HET). NCT02773420. Available from: https://clini-caltrials.gov/ct2/show/NCT02773420?recrs=e&cond=hemorrhoids
[110]
Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids (Hydro/Lido). NCT02689856. Available from: https://clinicaltrials.gov/ct2/show/NCT02689856?recrs=e&cond=hemorrhoids
[111]
Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids: Band Ligation and Electrocoagulation Probe. NCT00630669. Available from: https://clinicaltrials.gov/ct2/show/NCT00630669?recrs=e&cond=hemorrhoids
[112]
Hemoclin Gel for the Treatment of Hemorrhoids. NCT05124379. Available from: https://clinicaltrials.gov/ct2/show/NCT05124379?recrs=e&cond=hemorrhoids
[113]
Efficacy of Lidocaine Gel Enema After Endoscopic Hemorrhoid Band Ligation for Relief of Post Procedural Pain. NCT03797703. Available from: https://clinicaltrials.gov/ct2/show/NCT03797703?recrs=e&cond=hemorrhoids
[114]
Efficacy Study of Iferanserin to Treat Hemorrhoids. NCT01483833. Available from: https://clinicaltrials.gov/ct2/show/NCT01483833?recrs=e&cond=hemorrhoids
[115]
Study of the Safety and Efficacy of Hydrocortisone Acetate Suppositories, 25 mg in the Treatment of Symptomatic Internal Hemorrhoids. NCT03335774. Available from: https://clinicaltrials.gov/ct2/show/NCT03335774?recrs=e&cond=hemorrhoids
[116]
Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids Using the HEM-AVERT Perianal Stabilizer Instrument (HEM-AVERT). NCT00487045. Available from: https://clinicaltrials.gov/ct2/show/NCT00487045?recrs=e&cond=hemorrhoids
[117]
Safety and Short Term Effectiveness of EEA Versus PPH Stapler for III Degree Hemorrhoids (EEA/PPH2011). NCT01413867. Available from: https://clinicaltrials.gov/ct2/show/NCT01413867?recrs=e&cond=hemorrhoids
[118]
Hemorrhoids and Metalloproteinases, Observational Study (HeMe). NCT02358174. Available from: https://clinicaltrials.gov/ct2/show/NCT02358174?recrs=e&cond=hemorrhoids
[119]
Pain Relief for Thrombosed External Haemorrhoids. NCT00717782. Available from: https://clinicaltrials.gov/ct2/show/NCT00717782?recrs=e&cond=hemorrhoids
[120]
Topical Anesthesia Versus Placebo to Decrease Pain in Rubber Band Ligation for Treatment of Internal Hemorrhoids. NCT02130830. Available from: https://clinicaltrials.gov/ct2/show/NCT02130830?recrs=e&cond=hemorrhoids
[121]
Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids. NCT03298997. Available from: https://clinicaltrials.gov/ct2/show/NCT03298997?recrs=e&cond=hemorrhoids
[122]
Transanal Hemorrhoidal Dearterialization (THD) vs. Hemorrhoidectomy (THD). NCT01244672. Available from: https://clini-caltrials.gov/ct2/show/NCT01244672?recrs=e&cond=hemorrhoids
[123]
Longo's Intervention in the Treatment of Hemorrhoids and Rectal Mucosal Prolapse. NCT03383926. Available from: https://clini-caltrials.gov/ct2/show/NCT03383926?recrs=e&cond=hemorrhoids
[124]
Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids. NCT00841620. Available from: https://clinicaltrials.gov/ct2/show/NCT00841620?recrs=e&cond=hemorrhoids
[125]
Doppler-guided Haemorrhoidal Artery Ligation With Suture Mucopexy vs. Suture Mucopexy Alone. NCT02372981. Available from: https://clinicaltrials.gov/ct2/show/NCT02372981?recrs=e&cond=hemorrhoids
[126]
Safety and Efficacy of the Addition of Morphine Chloride to a Low Dose of Bupivacaine as Intradural Anaesthetic for the Removal Surgery of the Hemorrhoids. NCT02046772. Available from: https://clinicaltrials.gov/ct2/show/NCT02046772?recrs=e&cond=hemorrhoids
[127]
A Prospective, Randomized, Three Arms, Open Label Study Comparing the Safety and Efficacy of Two Formulations of PP110 to the Active Comparator Preparation-H® Cream in the Treatment of Bleeding Hemorrhoids Grades 2-3. NCT02010099. Available from: https://clinicaltrials.gov/ct2/show/NCT02010099?recrs=e&cond=hemorrhoids
[128]
Comparison Between Excisional. Hemorrhoidectomy and Haemorrhoidal Dearterialisation With Anopexy. Available from: https://clinicaltrials.gov/ct2/show/NCT01263431?recrs=e&cond=hemorrhoids
[129]
Bleeding in Laser Haemorrhoidoplasty. NCT04667169. Available from: https://clinicaltrials.gov/ct2/show/NCT04667169?recrs=e&cond=hemorrhoids
[130]
Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy. NCT00744848. Available from: https://clinicaltrials.gov/ct2/show/NCT00744848?recrs=e&cond=hemorrhoids
[131]
Study of a New Circular Anal Dilator. NCT00693459. Available from: https://clinicaltrials.gov/ct2/show/NCT00693459?recrs=e&cond=hemorrhoids
[132]
Polidocanol Foam vs. Artery Ligation in Hemorrhoidal Disease. NCT04675177. Available from: https://clinicaltrials.gov/ct2/show/NCT04675177?recrs=e&cond=hemorrhoids
[133]
Study of Pain Control in Hemorrhoidectomy. NCT00890721. Available from: https://clinicaltrials.gov/ct2/show/NCT00890721?recrs=e&cond=hemorrhoids
[134]
Minimal Invasive Laser Hemorrhoidoplasty vs. Conventional Excisional Hemorrhoidectomy in II-III Grade Hemorrhoidal Disease. NCT04944407. Available from: https://clinicaltrials.gov/ct2/show/NCT04944407?recrs=e&cond=hemorrhoids
[135]
Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease. NCT03545724. Available from: https://clinicaltrials.gov/ct2/show/NCT03545724?recrs=e&cond=hemorrhoids
[136]
Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease. NCT02782455. Available from: https://clinicaltrials.gov/ct2/show/NCT02782455?recrs=e&cond=hemorrhoids
[137]
Study About Patient Comfort and Long-term Outcome After Stapled Hemorrhoidopexy. NCT01533363. Available from: https://clinicaltrials.gov/ct2/show/NCT01533363?recrs=e&cond=hemorrhoids
[138]
Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy. NCT02328144. Available from: https://clinicaltrials.gov/ct2/show/NCT02328144?recrs=e&cond=hemorrhoids
[139]
Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease (SCLEROFOAM). NCT03791775. Available from: https://clinicaltrials.gov/ct2/show/NCT03791775?recrs=e&cond=hemorrhoids
[140]
Subarachnoid or Infiltration for Hemorrhoidectomy. NCT01927874. Available from: https://clinicaltrials.gov/ct2/show/NCT01927874?recrs=e&cond=hemorrhoids
[141]
Transanal Haemorrhoidal Dearterialisation Versus Stapler Haemorrhoidopexy. NCT01615575. Available from: https://clinical-trials.gov/ct2/show/NCT01615575?recrs=e&cond=hemorrhoids
[142]
Local Anaesthetic Day-Care Haemorrhoidectomy Challenges Traditional Concepts - a Randomised Controlled Trial. NCT00503269. Available from: https://clinicaltrials.gov/ct2/show/NCT00503269?recrs=e&cond=hemorrhoids
[143]
Polidocanol Foam Versus Rubber Band Ligation in the Treatment of Hemorrhoidal Disease. NCT04091763. Available from: https://clinicaltrials.gov/ct2/show/NCT04091763?recrs=e&cond=hemorrhoids
[144]
Treatment of Thrombosed Haemorrhoids in Pregnancy. NCT04588467. Available from: https://clinicaltrials.gov/ct2/show/NCT04588467?recrs=e&cond=hemorrhoids
[145]
Effect of Perioperative i.v. Low-dose S(+) Ketamine. NCT00354029. Available from: https://clinicaltrials.gov/ct2/show/NCT00354029?recrs=e&cond=hemorrhoids
[146]
Pudendal FM. Nerve Block for Hemorrhoidectomy. NCT04251884. Available from: https://clinicaltrials.gov/ct2/show/NCT04251884?recrs=e&cond=hemorrhoids
[147]
Topical Versus Oral Metronidazole Following Excisional Haemorrhoidectomy. NCT03343509. Available from: https://clinicaltrials.gov/ct2/show/NCT03343509?recrs=e&cond=hemorrhoids
[148]
Anesthesia With Heavy Prilocaine-Fentanyl and Heavy Bupivacaine-Fentanyl. NCT01880775. Available from: https://clinical-trials.gov/ct2/show/NCT01880775?recrs=e&cond=hemorrhoids
[149]
Perineal Self-Acupressure. NCT01867944. Available from: https://clinicaltrials.gov/ct2/show/NCT01867944?recrs=e&cond=hemorrhoids
[150]
Effect of Early Warm Water Sitz Bath on Urinary Retention After Hemorrhoidectomy. NCT04535765. Available from: https://clinicaltrials.gov/ct2/show/NCT04535765?recrs=e&cond=hemorrhoids
[151]
Trial of Open Milligan-Morgan Haemorrhoidectomy Versus Laser Closed Haemorrhoidectomy. NCT01342991. Available from: https://clinicaltrials.gov/ct2/show/NCT01342991?recrs=e&cond=hemorrhoids
[152]
Perianal Nerval Block in Proctological Interventions. NCT03405922. Available from: https://clinicaltrials.gov/ct2/show/NCT03405922?recrs=e&cond=hemorrhoids
[153]
Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery. NCT02961855. Available from: https://clinicaltrials.gov/ct2/show/NCT02961855?recrs=e&cond=hemorrhoids
[154]
Randomized Controlled Trial Comparing Transanal Dopplerguided Arterial Ligation With Mucopexy and Stapled Haemorrhoidopexy (LIGALONGO). NCT01240772. Available from: https://clinicaltrials.gov/ct2/show/NCT01240772?recrs=e&cond=hemorrhoids
[155]
Ming L, Liping M, Faxiang L. Medication for preventing and treating hemorrhoids and use thereof. CN Patent: 112138054A, 2020.
[156]
Zhangyong C. Hemorrhoid powder for treating hemorrhoids and preparation method thereof. Patent: CN112168879A, 2021.
[157]
Yong X. Chinese herbal medicine spray for treating hemorrhoids. Patent: CN107233405B, 2020.
[158]
Kangquan L. Binghuang hemorrhoids ointment. CN107213402B, 2020.
[159]
Ming G. Ointment for treating hemorrhoids and using method thereof. Patent: CN110882301, 2020.
[160]
Yoo-hee K. Foldable seat for hemorrhoids. WO Patent: 2021194209A1, 2021.
[161]
Smith P, Cloyd T, Rausae J, et al. System, device and method for treatment of hemorrhoids. US Patent: 0022746A1, 2021.
[162]
Jingsen X. Traditional Chinese medicine patch for treating hemorrhoids. CN Patent: 105920174A, 2016.
[163]
Piskun G. Rubber band ligation system for treatment of hemorrhoids. US Patent: 0177424, 2021.
[164]
Zhenfeng W, Xiaoying H, Ming Y, et al. Compound essential oil for treating hemorrhoids and preparation method and use method thereof. CN Patent: 108853293B, 2021.
[165]
Young-gyu K, Soon-gyu I, Maeng C, Hong-goo K. Herbal composition for treating hemorrhoids. Patent: KR101827841B1, 2018.
[166]
Sukun Y. Oral administration medicament for treating hemorrhoids and application thereof. CN Patent: 105902711A, 2016.
[167]
Sukun Y. Externally applied medicine for treating hemorrhoids and application thereof. CN Patent: 105998541, 2016.
[168]
Fujiang Q, Wenpeng Z, Zhenggui D, Ling L. Traditional Chinese medicine composition for preventing and treating hemorrhoids, preparation method and application thereof, and hemorrhoids cream. CN Patent: 105726733A, 2016.
[169]
Yuewei H. External preparation for treating hemorrhoids and preparation method thereof. CN Patent: 106619803B, 2020.
[170]
Jung M, Chang-young C. Banana clip for removing hemorrhoids and Surgical tool set including the same. KR Patent: 102092347B1, 2020.
[171]
Weisheng L. Preparation process of radix paeoniae alba for treating hemorrhoids. CN Patent: 113181247A, 2021.
[172]
Ruijian W, Hongyan W. Oral medicine for treating hemorrhoids and preparation method thereof. CN Patent: 105998880B, 2021.
[173]
Xuan W, Xunqi L, Yanwei Y. Externally applied medicine Tong hemorrhoid powder for treating hemorrhoids. CN Patent: 112190611A, 2021.
[174]
Chengfu Z. Preparation method and device of medicament for treating hemorrhoids through navel-pasting wet-dressing therapy. CN Patent: 113209171A, 2021.
[175]
Hong J. Seat for improving hemorrhoids by complex stimulus. KR Patent: 102379354B1, 2022.
[176]
Baocai L, Xitong K, Yufang K, et al. Compound ointment for treating hemorrhoids and preparation method of compound ointment. CN Patent: 105943655A, 2016.
[177]
Ruquan Z. Oral medicine for treating hemorrhoids and preparation method thereof. CN Patent: 112043729A, 2020.
[178]
Kolbas YY, Kuznetsov EY, Zhizhin NK. Method for treating acute hemorrhoids using laser hemorrhoidectomy. RU Patent: 2765920C, 2022.
[179]
Junzhang L. Medicinal liquor for treating hemorrhoids and preparation and use methods thereof. CN Patent: 113499370A, 2021.
[180]
Juhua L. Biological beverage for treating hemorrhoids and preparation method thereof. CN Patent: 112007141A, 2020.
[181]
Ziye's Z, Chenxiang W, Guanxian L. Natural product composition for treating hemorrhoids and preparation method thereof. CN Patent: 110403983B, 2021.
[182]
Zelu L. Medicine for treating hemorrhoids and preparation method thereof. CN Patent: 112691104A, 2021.
[183]
Youyun Q, Liping Q. Chinese herbal medicine oral pill for treating hemorrhoids. CN Patent: 112755119A, 2021.
[184]
Tanaka H, Tanaka H. Hemorrhoids and constipation treatment equipment. JP Patent: 3228281U, 2020.
[185]
Zhipeng L, Xia L, Yun S, et al. Traditional Chinese medicine composition for treating damp-heat downward flow type hemorrhoids and fistula. CN Patent: 112043767A, 2020.
[186]
Uzhtu U. Application of sweet potato as medicine for treating hemorrhoids. CN Patent: 107080762B, 2020.
[187]
Rebar H, Cummings NT, Belkhayat N, Weber J, Powers J, Murray C. Device, system and method for treatment of hemorrhoids. US Patent: 20210015506A, 2021.
[188]
Lianghui Z. Portable anus plug for treating hemorrhoids. CN213217942U, 2021.
[189]
Jian Z. Medicine for treating hemorrhoids and preparation method thereof. CN Patent: 110840985, 2020.
[190]
Windheuser K, Tabur P. Device and methods for inspection and treatment of hemorrhoids. US Patent: 20210015354A, 2021.
[191]
Qin Z. External preparation for treating hemorrhoids and preparation method thereof. CN Patent: 111110745A, 2020.
[192]
Xiaomei Z, Wenjun Y, Zhijun Y, Zhiyao C. Medicine for treating hemorrhoids. CN Patent: 111743948A, 2020.
[193]
Bhowmick N, Sharma DK, Aradhye CC, et al. Devices and methods for treatment of hemorrhoids. US Patent: 20210030424A1, 2021.
[194]
Hongfeng Z. Hemorrhoids ointment. CN110840965A, 2020.
[195]
Qin Z. Medicine for treating hemorrhoids and preparation method thereof. CN Patent: 111096998A, 2020.
[196]
Huijun W. Medicament for treating hemorrhoids and preparation method thereof. CN Patent: 111487599A, 2020.
[197]
Chaoqun X, Fangwenxiao X. Medicinal formula of product for treating hemorrhoids and preparation method thereof. CN Patent: 112755082A, 2021.
[198]
Qiling D, Yaqi D, Zejing L, Jiabiao S. Application of cobratide preparation in preparation of medicine for treating hemorrhoids. CN Patent: 110935009A, 2020.
[199]
Lizhi J. Constant-temperature cold therapy device for hemorrhoids. CN Patent: 212234921U, 2020.
[200]
Shilin Y, Hongwei G. Application of pulsatilla saponin B4 in preparation of medicine for treating hemorrhoids. CN Patent: 112370461A, 2021.
[201]
Keulenaer HD. Treatment of hemorrhoids with anticoagulant drugs. WO Patent: 2021115800A1, 2021.
[202]
Benqiang L. Externally applied traditional Chinese medicine composition for treating hemorrhoids. CN Patent: 111920865A, 2020.
[203]
Xuding S, Chenglei S, Tao J, Hongwei M. Application of Qiweidigu capsules to preparation of medicine for treating hemorrhoids. CN Patent: 105833201A, 2016.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy